Targeting HER2-low gastric cancer, summary by Erman Akkus

Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a recent article by K Shimozaki on X, adding:

“Targeting HER2-low gastric cancer at ESMO Open.

• Clinicopathological differences
• Available studies and ongoing trials
• Action mechanisms
• IHC criteria different from breast cancer.“
• 

HER2-low gastric cancer: is the subgroup targetable

Authors: K Shimozaki, S Fukuoka, A Ooki, and K Yamaguchi.

Source: Erman Akkus/X